Bionter Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Liquidation

Bionter General Information

Description

Developer of analytical testing devices designed for the benefit of people's health. The company's particle testing services are considered potentially critical for patient safety and sub-visible particle testing is mandatory for any parenteral preparation and is being used for stability testing, drug formulation, process development, and IPC testing during manufacturing, enabling clients to have new combination light obscuration technology and smart automation.

Contact Information

Website
www.bionter.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Inzlingerstrasse 238
  • 4125 Riehen
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Services
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Inzlingerstrasse 238
  • 4125 Riehen
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bionter Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Liquidation Completed Out of Business
6. Seed Round Completed Generating Revenue
5. Accelerator/Incubator 28-Sep-2022 Completed Generating Revenue
4. Seed Round 27-Apr-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2022 Completed Startup
2. Grant 18-May-2021 $11K $327K Completed Generating Revenue
1. Angel (individual) 19-Mar-2021 $327K $327K Completed Startup
To view Bionter’s complete valuation and funding history, request access »

Bionter Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred shares
Preferred shares
Preferred shares 659,586 $0.010641 $0.49 $0.49 1x $0.49 2.65%
Ordinary 9,230,577 $0.010641 $0.03 $0.03 1x $0.03 37.1%
To view Bionter’s complete cap table history, request access »

Bionter Patents

Bionter Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4514536-A1 Single-use, disposable container Pending 26-Apr-2022
US-12203954-B2 Single-use, disposable container Active 26-Apr-2022
US-20230341434-A1 Single-use, disposable container Active 26-Apr-2022
US-20250110145-A1 Single-use, disposable container Pending 26-Apr-2022
US-D1030471-S1 Single-use, disposable container Active 26-Apr-2022
To view Bionter’s complete patent history, request access »

Bionter Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bionter FAQs

  • When was Bionter founded?

    Bionter was founded in 2020.

  • Where is Bionter headquartered?

    Bionter is headquartered in Riehen, Switzerland.

  • What is the size of Bionter?

    Bionter has 7 total employees.

  • What industry is Bionter in?

    Bionter’s primary industry is Biotechnology.

  • Is Bionter a private or public company?

    Bionter is a Private company.

  • What is Bionter’s current revenue?

    The current revenue for Bionter is .

  • How much funding has Bionter raised over time?

    Bionter has raised $3.84M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process